why choose us

First received: December 12, 2022

Clinical Trial: Dose Finding Study to Evaluate Safety and Efficacy of 3 Dosages of SAP 001.

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Gout

Study Type: INTERVENTIONAL


Official Title: A Phase 2B Double-blind, Placebo-controlled, Dose-finding Study to Evaluate the Efficacy and Safety of 3 Dosages of SAP-001 in Combination With Standard of Care in Adult Subjects With Gout

Brief Summary: The aim of this study is to confirm the safety and pharmacological characteristics of SAP-001, evaluate its efficacy in lowering sUA and tophus burden, and identify the appropriate dose regimen for future studies in adult subjects with gout, with or without tophi, and hyperuricemia refractory to SoC XOI therapy.

Read more